Volume 27, Number 9—September 2021
Research Letter
SARS-CoV-2 Infection among Pregnant and Postpartum Women, Kenya, 2020–2021
Nancy A. Otieno1
, Eduardo Azziz-Baumgartner1, Bryan O. Nyawanda, Eunice Oreri, Sascha Ellington, Clayton Onyango, and Gideon O. Emukule
, Eduardo Azziz-Baumgartner1, Bryan O. Nyawanda, Eunice Oreri, Sascha Ellington, Clayton Onyango, and Gideon O. Emukule
Table
Characteristics of pregnant and postpartum women and their infants with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection, Kenya, May 2020–February 2021*
| Characteristic | Values |
|---|---|
| Women, n = 16 | |
| Days from onset to swabbing, mean (SD) | 2.6 (1.9) |
| Care-seeking from onset, d | |
| <2 | 11 (68.8) |
| >2 | 5 (31.3) |
| Self-reported symptoms | |
| Fever in past 48 h | 2 (12.5) |
| Measured fever >38.0°C | 2 (12.5) |
| Cough | 16 (100) |
| Shortness of breath | 1 (6.3) |
| Runny nose | 10 (62.5) |
| Headache | 10 (62.5) |
| Muscle/ joint pain | 2 (12.5) |
| Antimicrobial medication |
16 (100) |
| Infants, n = 2 | |
| Days from onset to swabbing, mean (SD) | 2.5 (2.1) |
| Care-seeking from onset, d | |
| <2 | 1 (50.0) |
| >2 | 1 (50.0) |
| Clinical signs reported by mother | |
| Fever in previous 48 h | 1 (50.0) |
| Measured fever >38.0°C | 1 (50.0) |
| Cough | 2 (100) |
| Runny nose | 1 (50.0) |
| Diarrhea | 1 (50.0) |
| Antimicrobial medication | 2 (100) |
*Values are no. (%) unless otherwise indicated.
1These authors contributed equally to this article.
Page created: June 21, 2021
Page updated: August 18, 2021
Page reviewed: August 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.